Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Dec. 31, 2024
Cash flows from operating activities:
Net loss	$ (8,488,967)	$ (10,603,477)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	1,253,882	1,630,011
Issuance of shares in consulting agreements	203,501	0
Amortization of debt discount	272,578	270,236
Depreciation expense	5,459	4,735
Finance lease depreciation expense	9,670	9,670
Changes in assets and liabilities:
Prepaid expenses and other assets	(3,395,931)	443,210
Accounts payable	1,174,424	(981,993)
Accrued expenses	(66,872)	(710,581)
Net cash used in operating activities	(9,032,256)	(9,938,189)
Cash flows from financing activities:
Proceeds from pre-funded warrants	1,009,969	0
Proceeds from exercise of pre-funded warrants	71	0
Proceeds from warrants	2,150,771	0
Proceeds from exercise of stock options	0	531,091
Payments of finance lease obligations	(14,761)	(13,475)
Loan principal repayment	(3,125,000)	0
Proceeds from issuance of common stock from the Sales Agreement, net	306,115	19,494,473
Proceeds from issuance of common stock, net of issuance costs	6,994,174	0
Net cash provided by financing activities	7,321,339	20,012,089
Net increase in cash and cash equivalents	(1,710,917)	10,073,900
Cash and cash equivalents at beginning of period	41,689,591	56,560,517	$ 56,560,517
Cash and cash equivalents at the end of period	39,978,674	66,634,417	$ 41,689,591
Supplemental information of cash and non-cash transactions:
Cash paid for interest	$ 693,989	$ 1,174,745